Skip to main content
Encision Inc. (ECIA)
OTCMKTS: ECIA · Delayed Price · USD
0.360
+0.002 (0.53%)
Jul 26, 2024, 3:15 PM EDT - Market closed

Encision Revenue

In the fiscal year ending March 31, 2024, Encision had annual revenue of $6.59M, down -10.38%. Encision had revenue of $1.52M in the quarter ending March 31, 2024, a decrease of -15.57%.

Revenue (ttm)
$6.59M
Revenue Growth
-10.38%
P/S Ratio
0.65
Revenue / Employee
$199,563
Employees
33
Market Cap
4.27M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 20246.59M-762.63K-10.38%
Mar 31, 20237.35M-320.12K-4.17%
Mar 31, 20227.67M130.80K1.74%
Mar 31, 20217.54M-132.37K-1.73%
Mar 31, 20207.67M-1.13M-12.86%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 379.49B
Johnson & Johnson 81.80B
Merck & Co. 61.40B
AbbVie 54.40B
Novartis AG 48.86B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Abbott Laboratories 40.33B
Revenue Rankings

ECIA News

More News